1.
Ahasan MH, Mahmood M, Adhikary DK, Ahsan SA, Ahmed CM, Salim MA, et al. Comparison of Safety and Efficacy Between Dabigatran and Rivaroxaban in Nonvalvular Atrial Fibrillation in Tertiary Level Hospital. Univ. Heart J. [Internet]. 2022 Jan. 31 [cited 2026 May 21];18(1):10-3. Available from: https://banglajol.info/index.php/UHJ/article/view/57874